2014
DOI: 10.15587/2313-8416.2014.32109
|View full text |Cite
|
Sign up to set email alerts
|

Раціональний Вибір Монотерапії Для Лікування Цд 2 Типу На Основі Фармакоекономічного Аналізу

Abstract: Research was conducted to scientific justification of rational choice of monotherapy diabetes mellitus (DM) type 2 based on the pharmacoeconomical analysis. It has been found that the unit of efficiency was the cheapest in the scheme of the monotherapy with gliclazide and most expensive-in the scheme of the monotherapy with metformin

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2019
2019
2021
2021

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 3 publications
0
1
0
Order By: Relevance
“…Almost 104,000 Ukrainians have been diagnosed with diabetes for the first time in 2017 -2% more than in 2016. [1,2] During from ten to fifteen years, diabetes can be cause a great deal of damage to the whole body, especially if there are significant complications, even if all the requirements for treatment and diet are met. Most often, with this disease, the composition of the blood changes, which leads to chronic damage to all vital organs.…”
Section: Introductionmentioning
confidence: 99%
“…Almost 104,000 Ukrainians have been diagnosed with diabetes for the first time in 2017 -2% more than in 2016. [1,2] During from ten to fifteen years, diabetes can be cause a great deal of damage to the whole body, especially if there are significant complications, even if all the requirements for treatment and diet are met. Most often, with this disease, the composition of the blood changes, which leads to chronic damage to all vital organs.…”
Section: Introductionmentioning
confidence: 99%